Choksi Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Choksi Laboratories Ltd. on BSE

Load latest

Choksi Laboratories Ltd.

29 May 2023

115.70

-1.15%

Board Meeting

CHOKSI LABORATORIES LTD. - 526546 - Board Meeting Outcome for Board Meeting Outcome For Outcome Of …

BSE India

1. Approved and taken on record 'Audited Standalone Financial Results' for the Fourth quarter and year ended on 31st March, 2023 along with the Auditors Report, pursuant to Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Declaration in respect of Unmodified opinion under Regulation 33(3)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. Approved the appointment of M/s, Tannmay V. Rajkumar & Co. as Internal Auditor of the Company for the Financial year 2022-23; 3. Noting of Letter received form Mr. Ratnesh Sadoriya for showing his interest, not to re-appoint him as Independent Director;

pdf

Choksi Laboratories Ltd.

29 May 2023

115.70

-1.15%

Result

CHOKSI LABORATORIES LTD. - 526546 - Approved And Taken On Record 'Audited Standalone Financial Results' For …

BSE India

pdf

Choksi Laboratories Ltd.

29 May 2023

115.70

-1.15%

Result

CHOKSI LABORATORIES LTD. - 526546 - Approved And Taken On Record 'Audited Standalone Financial Results' For …

BSE India

pdf

Choksi Laboratories Ltd.

29 May 2023

115.70

-1.15%

Annual Report

Annual report for Choksi Laboratories Ltd. for FY-2023

None

pdf

Choksi Laboratories Ltd.

26 May 2023

115.70

-1.15%

Company Update

CHOKSI LABORATORIES LTD. - 526546 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Submission of Annual Secretarial Compliance Report (ASCR) for the financial year ended 31st March, 2023 pursuant to Regulation 24A of SEBI (LODR) Regulations, 2015

pdf

Choksi Laboratories Ltd.

20 May 2023

115.70

-1.15%

Board Meeting

CHOKSI LABORATORIES LTD. - 526546 - Board Meeting Intimation for Board Meeting Intimation For Board Meeting …

BSE India

CHOKSI LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve 1. To consider and approve the standalone Audited Financial Result of the Company for the fourth Quarter and Year ended on 31st March 2023 2. To appoint Internal Auditor of the Company for the Financial Year 2023-24; and any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting which shall include at atleast one lndependent Director. if any.

pdf

Choksi Laboratories Ltd.

12 May 2023

115.70

-1.15%

Corp. Note

CHOKSI LABORATORIES LTD. - 526546 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

INTIMATION OF INFORMATION RECEIVED UNDER REGULATION 39(3) OF THE SEBI (LISTING OBLIGATION AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015

pdf

Choksi Laboratories Ltd.

27 Apr 2023

115.70

-1.15%

Company Update

CHOKSI LABORATORIES LTD. - 526546 - Clarification On Price Movement

BSE India

Announcement under Regulation 30 (LODR)

pdf

Choksi Laboratories Ltd.

27 Apr 2023

115.70

-1.15%

Company Update

CHOKSI LABORATORIES LTD. - 526546 - Clarification sought from Choksi Laboratories Ltd

BSE India

The Exchange has sought clarification from Choksi Laboratories Ltd on April 26, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.

Choksi Laboratories Ltd.

17 Apr 2023

115.70

-1.15%

Corp. Note

CHOKSI LABORATORIES LTD. - 526546 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyCHOKSI LABORATORIES LTD. 2CIN NO.L85195MP1993PLC007471 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 30.73 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Yash Gupta Designation: Company Secretary and Compliance Officer EmailId: compliance_officer@choksilab.com Name of the Chief Financial Officer: Vyangesh Choksi Designation: Chief Financial Officer EmailId: v.choksi@choksilab.com Date: 17/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Is Choksi Laboratories Ltd. worth buying?

8 Votes:

Buy 37.5%

Sell 25.0%

Hold 37.5%